- Home
- CMRX
CMRX
Chimerix Inc.
as 11-15-2024 4:00pm EST
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.
| Founded: | 2000 | Country: | United States |
| Employees: | N/A | City: | DURHAM |
| Market Cap: | 77.1M | IPO Year: | 2013 |
| Target Price: | $11.00 | AVG Volume (30 days): | 282.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.94 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.75 - $1.30 | Next Earning Date: | 11-07-2024 |
| Revenue: | $159,000 | Revenue Growth: | -85.98% |
| Revenue Growth (this year): | 1772.84% | Revenue Growth (next year): | -65.95% |
Latest Chimerix Inc. News
CMRX Breaking Stock News: Dive into CMRX Ticker-Specific Updates for Smart Investing
GlobeNewswire
6 days ago
Chimerix Announces Updated Phase 2 Response Assessment of Dordaviprone in Recurrent H3 K27M Glioma at the 2024 SNO Meeting
Simply Wall St.
8 days ago
Chimerix Third Quarter 2024 Earnings: Misses Expectations
Thomson Reuters StreetEvents
10 days ago
Q3 2024 Chimerix Inc Earnings Call
GuruFocus.com
10 days ago
Chimerix Inc (CMRX) Q3 2024 Earnings Call Highlights: Strategic Advancements Amid Financial ...
Zacks
10 days ago
Chimerix (CMRX) Reports Q3 Loss, Lags Revenue Estimates
Associated Press Finance
10 days ago
Chimerix: Q3 Earnings Snapshot
GlobeNewswire
10 days ago
Chimerix Reports Third Quarter 2024 Financial Results and Provides Operational Update
GuruFocus.com
11 days ago
Chimerix Inc (CMRX) Q3 2024: Everything You Need to Know Ahead of Earnings
Compare CMRX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CMRX Chimerix Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.